AQST logo

Aquestive Therapeutics (AQST) Net Income

Annual Net Income

-$7.87 M
+$46.54 M+85.54%

December 31, 2023

Summary

Performance

1-Year Change

+85.54%

3-Year Change

+85.89%

5-Year Change

+87.18%

15-Year Change

+12%

AQST Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

72.85%
AQST annual net profit is higher than 72.85% of companies in Healthcare sector

High & Low

All-time High

-$7.87 M
AQST annual net profit is currently at an all-time high

3-Year Low

-$70.54 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
AQST previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 5, 2025
AQST next annual earnings announcement is scheduled for Mar 5, 2025

OtherAQSTprofitabilitymetrics:

Annual Net Margin

-15.56%
AQST annual net profit margin is -15.56%

Annual Revenue

$50.58 M
AQST annual revenue is $50.58 million

Annual Gross Profit

$29.75 M
AQST annual gross profit is $29.75 million

Annual EPS

-$0.13
AQST annual earnings per share is -$0.13

Quarterly Net Income

-$11.51 M
-$8.76 M-319.27%

September 30, 2024

Summary

Performance

3-Month Change

-319.27%

1-Year Change

-465.55%

3-Year Change

-465.55%

5-Year Change

-465.55%

AQST Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.76%
AQST quarterly net profit is higher than 37.76% of companies in Healthcare sector

High & Low

All-time High

$8.45 M
AQST quarterly net profit is currently -236.19% below its historical high of $8.45 million

3-Year Low

-$28.95 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AQST previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
AQST next earnings announcement is scheduled for Mar 5, 2025

OtherAQSTprofitabilitymetrics:

Quarterly Net Margin

-84.99%
AQST quarterly net profit margin is -84.99%

Quarterly Revenue

$13.54 M
AQST quarterly revenue is $13.54 million

Quarterly Gross Profit

$9.11 M
AQST quarterly gross profit is $9.11 million

Quarterly EPS

-$0.13
AQST quarterly earnings per share is -$0.13

TTM Net Income

-$35.19 M
-$9.47 M-36.84%

September 30, 2024

Summary

Performance

3-Month Change

-36.84%

1-Year Change

-190.59%

3-Year Change

-190.59%

5-Year Change

-190.59%

AQST TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.37%
AQST TTM net profit is higher than 44.37% of companies in Healthcare sector

High & Low

All-time High

$1.10 M
AQST TTM net profit is currently -3308.11% below its historical high of $1.10 million

3-Year Low

-$73.02 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AQST previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
AQST next earnings announcement is scheduled for Mar 5, 2025

OtherAQSTprofitabilitymetrics:

Annual Net Margin

-15.56%
AQST annual net profit margin is -15.56%

TTM Revenue

$58.90 M
AQST TTM revenue is $58.90 million

TTM Gross Profit

$40.87 M
AQST TTM gross profit is $40.87 million

TTM EPS

-$0.46
AQST TTM earnings per share is -$0.46

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$7.87 M
AQST annual net profit is -$7.87 million

Annual Revenue

$50.58 M
AQST annual revenue is $50.58 million

Annual Cost Of Goods Sold

$20.83 M
AQST annual cost of goods sold is $20.83 million

Annual Operating Expenses

$44.85 M
AQST annual total operating expenses is $44.85 million

Annual Interest Expense

$7.46 M
AQST annual interest expense is $7.46 million

Annual Income Tax

$245.00 K
AQST annual income tax is $245.00 thousand

AQST Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+85.5%-465.6%-190.6%
3 y3 years+85.9%-465.6%-190.6%
5 y5 years+87.2%-465.6%-190.6%

AQST Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+88.8%-242.7%+60.2%-347.2%+51.8%
5 y5-yearat high+88.8%-242.7%+60.2%-347.2%+51.8%
alltimeall timeat high+88.8%-236.2%+68.5%-3308.1%+56.1%

Aquestive Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$11.51 M(+319.3%)
-$35.19 M(+36.8%)
Jun 2024
-
-$2.75 M(-78.6%)
-$25.72 M(-10.6%)
Mar 2024
-
-$12.83 M(+58.2%)
-$28.77 M(+265.5%)
Dec 2023
-$7.87 M(-85.5%)
-$8.11 M(+298.6%)
-$7.87 M(-35.0%)
Sep 2023
-
-$2.04 M(-64.9%)
-$12.11 M(-46.4%)
Jun 2023
-
-$5.79 M(-171.8%)
-$22.61 M(-31.7%)
Mar 2023
-
$8.07 M(-165.3%)
-$33.12 M(-39.1%)
Dec 2022
-$54.41 M(-22.9%)
-$12.35 M(-1.5%)
-$54.41 M(-23.4%)
Sep 2022
-
-$12.54 M(-23.1%)
-$71.00 M(-2.8%)
Jun 2022
-
-$16.30 M(+23.3%)
-$73.02 M(+5.7%)
Mar 2022
-
-$13.22 M(-54.3%)
-$69.09 M(-2.1%)
Dec 2021
-$70.54 M(+26.5%)
-$28.95 M(+98.9%)
-$70.54 M(+13.8%)
Sep 2021
-
-$14.55 M(+17.7%)
-$61.96 M(-3.1%)
Jun 2021
-
-$12.37 M(-15.7%)
-$63.96 M(+18.6%)
Mar 2021
-
-$14.67 M(-28.0%)
-$53.92 M(-3.3%)
Dec 2020
-$55.78 M
-$20.37 M(+23.1%)
-$55.78 M(+16.1%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$16.55 M(+609.1%)
-$48.05 M(-3.7%)
Jun 2020
-
-$2.33 M(-85.9%)
-$49.91 M(-26.7%)
Mar 2020
-
-$16.53 M(+30.8%)
-$68.05 M(+2.7%)
Dec 2019
-$66.25 M(+7.9%)
-$12.64 M(-31.4%)
-$66.25 M(-1.9%)
Sep 2019
-
-$18.41 M(-10.1%)
-$67.55 M(+5.3%)
Jun 2019
-
-$20.47 M(+39.0%)
-$64.18 M(-20.0%)
Mar 2019
-
-$14.73 M(+5.6%)
-$80.20 M(+30.7%)
Dec 2018
-$61.38 M(+586.3%)
-$13.94 M(-7.3%)
-$61.38 M(+6.8%)
Sep 2018
-
-$15.04 M(-58.8%)
-$57.47 M(+69.1%)
Jun 2018
-
-$36.49 M(-990.3%)
-$33.98 M(+903.3%)
Mar 2018
-
$4.10 M(-140.8%)
-$3.39 M(-62.1%)
Dec 2017
-$8.94 M(-6.9%)
-$10.04 M(-218.8%)
-$8.94 M(-915.2%)
Sep 2017
-
$8.45 M(-243.3%)
$1.10 M(-114.9%)
Jun 2017
-
-$5.90 M(+304.7%)
-$7.35 M(+404.7%)
Mar 2017
-
-$1.46 M
-$1.46 M
Dec 2016
-$9.60 M
-
-

FAQ

  • What is Aquestive Therapeutics annual net profit?
  • What is the all time high annual net income for Aquestive Therapeutics?
  • What is Aquestive Therapeutics annual net income year-on-year change?
  • What is Aquestive Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Aquestive Therapeutics?
  • What is Aquestive Therapeutics quarterly net income year-on-year change?
  • What is Aquestive Therapeutics TTM net profit?
  • What is the all time high TTM net income for Aquestive Therapeutics?
  • What is Aquestive Therapeutics TTM net income year-on-year change?

What is Aquestive Therapeutics annual net profit?

The current annual net income of AQST is -$7.87 M

What is the all time high annual net income for Aquestive Therapeutics?

Aquestive Therapeutics all-time high annual net profit is -$7.87 M

What is Aquestive Therapeutics annual net income year-on-year change?

Over the past year, AQST annual net profit has changed by +$46.54 M (+85.54%)

What is Aquestive Therapeutics quarterly net profit?

The current quarterly net income of AQST is -$11.51 M

What is the all time high quarterly net income for Aquestive Therapeutics?

Aquestive Therapeutics all-time high quarterly net profit is $8.45 M

What is Aquestive Therapeutics quarterly net income year-on-year change?

Over the past year, AQST quarterly net profit has changed by -$9.47 M (-465.55%)

What is Aquestive Therapeutics TTM net profit?

The current TTM net income of AQST is -$35.19 M

What is the all time high TTM net income for Aquestive Therapeutics?

Aquestive Therapeutics all-time high TTM net profit is $1.10 M

What is Aquestive Therapeutics TTM net income year-on-year change?

Over the past year, AQST TTM net profit has changed by -$23.08 M (-190.59%)